Wholly owned Italian subsidiary CFS Europe S.p.A. faces liquidation appeal

Regulatory & Legal View source PDF Explain this filing

CAMLINFINE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.9%Reaction day

₹148.37

prior close

₹145.10

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%+2.2% vs market

Specialty Chemicals peers, median of 89sector-1.4%+2.3% vs sector

On the reaction day the stock moved 2.2 pts more than Nifty Microcap 250 and 2.3 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

-0.6

15m

-0.1

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.9-1.3+2.2-1.4+2.3

Next day

-4.3-4.0-0.3-3.3-1.0

-8.4-4.8-3.6-4.6-3.8

-1.4-3.3+1.8-3.5+2.1

-4.3-5.3+1.1-3.9-0.4

-6.0-5.2-0.8-5.0-1.0

-4.7-3.7-1.0-3.4-1.3

15d

+12.6+3.6+9.0+0.9+11.7

-4.6+0.1-4.7-2.8-1.8

-19.5-8.9-10.6-10.8-8.7

-30.1+3.2-33.3-2.0-28.1

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 89Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Camlin Fine Sciences' wholly owned Italian subsidiary CFS Europe S.p.A., which makes industrial chemicals like hydroquinone and catechol, faces liquidation proceedings. The Board of Statutory Auditors filed an appeal on January 15, 2026 with the Tribunal of Ravenna, citing inability to pay overdue debts and fund recovery investments. The subsidiary had already closed its Diphenol Plant in 2023 due to weak demand, high energy costs, and the Russia-Ukraine conflict. Company says it is too early to assess further impact and will update exchanges as developments occur.

Likely market impact

Negative for shareholders; signals financial distress at subsidiary level, potential write-downs, and added pressure on the stock price.